Online Blue Pills
Geftib 250 MG Tablet is a medication used in the treatment of certain types of cancer, specifically non-small cell lung cancer (NSCLC) that is associated with specific genetic mutations. The active ingredient in Geftib 250 MG is Gefitinib, which belongs to a class of medications known as tyrosine kinase inhibitors. You can buy Geftib 250 MG Tablets online in the USA/UK from Online Blue Pills at best prices.

Generic Name : Gefitinib

Brand Name : Iressa

Manufacturer Name : Glenmark

Product Code : OBP 1081

Delivery Days : 10 To 12 Working Days

Composition : Gefitinib

Strength : 250mg

Packaging : Tablet (Blisters)

Presentation : Pills Strip

Drug Class : Kinase inhibitors

Prescribed For : Non-Small Cell Lung Cancer

Side Effects : Diarrhea, Fever, Allergic Skin Reaction

Pack Size/Qty Price Price Per Pill or unit  
90 TABLET'S $251.10 $2.79

Add to Cart

60 TABLET'S $170.40 $2.84

Add to Cart

30 TABLET'S $86.70 $2.89

Add to Cart

Descriptions

What is Geftib 250 MG Tablet?

Geftib 250 MG Tablet is a medication used in the treatment of non-small cell lung cancer (NSCLC), a type of lung cancer. The active ingredient in Geftib 250 MG is Gefitinib, which belongs to a class of drugs known as tyrosine kinase inhibitors.


How does Geftib 250 MG Tablet work?

Geftib 250 MG Tablet works by targeting a specific molecular pathway involved in the growth and division of cancer cells. The active ingredient in Geftib is Gefitinib, which belongs to a class of drugs known as tyrosine kinase inhibitors.

Mechanism of Action:

Inhibition of EGFR Tyrosine Kinase:

The primary target of Gefitinib is the epidermal growth factor receptor (EGFR), a protein that plays a key role in signaling pathways promoting cell growth and division.
Blocking Signaling Pathways:

Cancer cells often have mutations in the EGFR gene, leading to overactive signaling pathways that contribute to uncontrolled cell proliferation. Gefitinib inhibits the activity of the EGFR tyrosine kinase, disrupting these signaling pathways.
Cell Cycle Arrest:

By blocking EGFR signaling, Gefitinib interferes with the normal progression of the cell cycle. This can lead to a slowdown or arrest of the cancer cell division process.
Apoptosis Induction:

In addition to inhibiting cell proliferation, Gefitinib may promote apoptosis, which is a natural process of programmed cell death. Inducing apoptosis in cancer cells helps to eliminate them from the body.

 

Ingredients and dosages Geftib 250 MG Tablets

Ingredients:
The active ingredient in Geftib 250 MG Tablets is Gefitinib. Each tablet contains 250 milligrams of Gefitinib.

Dosage:
The dosage of Geftib 250 MG Tablets is determined by the healthcare provider based on the patient's medical condition, overall health, and specific requirements. The standard recommended dosage for adult patients with non-small cell lung cancer (NSCLC) is typically one 250 mg tablet taken orally once daily.


Who can use Geftib 250 MG Tablets?

Geftib 250 MG Tablets are typically prescribed for adult patients diagnosed with non-small cell lung cancer (NSCLC) who have specific mutations in the epidermal growth factor receptor (EGFR) gene. These mutations make the cancer cells more responsive to the inhibitory effects of Gefitinib, the active ingredient in Geftib 250 MG Tablets.

Key Considerations:

EGFR Mutations:

Geftib 250 MG Tablets are particularly suitable for individuals with NSCLC who have been tested positive for specific EGFR mutations. Genetic testing is usually conducted to identify the presence of these mutations in the tumor.
Non-Small Cell Lung Cancer (NSCLC):

Geftib is indicated for the treatment of advanced or metastatic NSCLC, where the tumors exhibit EGFR mutations. It is not typically used for other types of lung cancer or conditions.
Prescription by Healthcare Provider:

The decision to use Geftib 250 MG Tablets is made by healthcare providers based on a thorough assessment of the patient's medical condition, genetic profile, and overall health.
Individualized Treatment Plans:

Treatment plans are individualized, and the suitability of Geftib is determined by the healthcare provider. Factors such as overall health, medical history, and the presence of other medical conditions are considered.
Not Suitable for All Lung Cancers:

Geftib is not a first-line treatment for all types of lung cancer. Its effectiveness is specifically linked to the presence of EGFR mutations, and its use is generally reserved for cases where these mutations are identified.


Common mistakes to avoid Geftib 250 MG Tablets

Avoiding common mistakes is essential to ensure the safe and effective use of Geftib 250 MG Tablets. Here are key points to avoid:

Self-Adjusting Dosage:

Patients should not self-adjust the dosage of Geftib 250 MG Tablets. Any changes to the prescribed treatment plan should be discussed with and approved by the healthcare provider.
Skipping Doses Without Guidance:

Patients should not skip doses without consulting their healthcare provider. If a dose is missed, it's important to follow the guidance provided by the healthcare professional.
Not Taking the Medication as Directed:

Geftib 250 MG Tablets should be taken according to the prescribed schedule and instructions. Patients should not alter the timing or frequency of administration without consulting their healthcare provider.
Inconsistent Timing:

Patients are advised to take Geftib at the same time each day to maintain consistent levels of the medication in the body. Inconsistent timing may affect the effectiveness of the treatment.
Not Reporting Side Effects Promptly:

Prompt reporting of side effects to the healthcare provider is crucial. Common side effects may include rash, diarrhea, and changes in liver function tests. Severe or persistent side effects should be reported promptly.
Not Undergoing Regular Monitoring:

Regular medical check-ups and monitoring are essential during Geftib 250 MG treatment. Skipping or neglecting these appointments can result in missed opportunities to adjust the treatment plan based on the patient's response.
Ignoring Precautions:

Patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or other medications they are taking. Ignoring these considerations may lead to potential interactions or complications.
Not Seeking Guidance for Missed Doses:

If a dose is missed, patients should contact their healthcare provider for guidance on how to proceed. It is not advisable to self-adjust or double up on doses without professional advice.
Neglecting Communication:

Open communication with the healthcare provider is crucial. Patients should actively share any concerns, changes in health, or questions about the treatment with their healthcare team.
Pregnancy and Breastfeeding Considerations:

Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss these considerations with their healthcare provider. Geftib may have potential risks during pregnancy.


Buy Geftib 250 MG Tablets Online in USA from Online Blue Pills

Online Blue Pills is a leading online pharmacy for all your medical needs. If you want to shop Geftib 250 MG Tablets online in the USA, Online Blue Pills is your go-to destination. Get medicines at the most affordable prices and quickly delivered across the USA only from Online Blue Pills.

Faq

FAQs on Geftib 250 MG Tablets


Q: What is Geftib 250 MG Tablet used for?


A: Geftib 250 MG Tablet is used in the treatment of non-small cell lung cancer (NSCLC), particularly in cases where tumors have specific mutations in the epidermal growth factor receptor (EGFR) gene.


Q: How does Geftib 250 MG Tablet work?


A: Geftib 250 MG Tablet works by inhibiting the activity of the EGFR tyrosine kinase, a protein involved in the growth and division of cancer cells. This targeted approach is effective in cases with specific EGFR mutations.


Q: Can Geftib 250 MG Tablet be used for other types of cancer?


A: Geftib 250 MG Tablet is primarily indicated for non-small cell lung cancer with specific EGFR mutations. Its use for other types of cancer should be discussed with and approved by a healthcare provider.


Q: How is Geftib 250 MG Tablet administered?

A: Geftib 250 MG Tablet is taken orally, typically once a day. The tablets can be taken with or without food, as directed by the healthcare provider.


Q: What should I do if I miss a dose of Geftib 250 MG Tablet?


A: If a dose is missed, patients should contact their healthcare provider for guidance. It is generally not advisable to double up on doses to make up for a missed one.


Q: Can Geftib 250 MG Tablet be taken during pregnancy or breastfeeding?


A: Pregnant or breastfeeding individuals should discuss the potential risks and benefits of Geftib 250 MG Tablet with their healthcare provider. It may not be suitable for certain individuals during pregnancy or breastfeeding.


Q: How long should I take Geftib 250 MG Tablet?


A: The duration of Geftib 250 MG treatment is determined by the healthcare provider based on the patient's response to the medication and the progression of the disease. Patients should continue taking the medication for as long as prescribed.


Q: What are the common side effects of Geftib 250 MG Tablet?


A: Common side effects may include rash, diarrhea, nausea, vomiting, changes in liver function tests, decreased appetite, fatigue, dry skin, mouth sores, and nail changes. Patients should promptly report any severe or persistent side effects to their healthcare provider.


Q: Can Geftib 250 MG Tablet be used in children?


A: The safety and effectiveness of Geftib 250 MG Tablet in children may vary. Its use in pediatric patients should be determined by a healthcare provider based on individual cases.


Q: Can I adjust the dosage of Geftib 250 MG Tablet on my own?


A: Patients should not self-adjust the dosage of Geftib 250 MG Tablet. Any changes to the prescribed treatment plan should be discussed with and approved by the healthcare provider.

Side Effect

Common side effects of Geftib 250 MG Tablets

Common side effects of Geftib 250 MG Tablets may include:

Rash:

Skin rash is a common side effect. Patients should promptly report any rash to their healthcare provider.
Diarrhea:

Diarrhea can occur as a side effect. Staying hydrated and informing the healthcare provider about persistent diarrhea is important.
Nausea:

Some patients may experience nausea. Taking the medication with food or as directed by the healthcare provider may help alleviate this symptom.
Vomiting:

Vomiting may occur in some individuals. It's important to report persistent vomiting to the healthcare provider.
Changes in Liver Function Tests:

Geftib can affect liver function, leading to changes in liver enzyme levels. Regular monitoring of liver function is typically conducted during treatment.
Decreased Appetite:

Some patients may experience a decrease in appetite. Maintaining a balanced diet and discussing any significant changes with the healthcare provider is advisable.
Fatigue:

Feeling tired or experiencing fatigue is a common side effect. Patients should inform their healthcare provider if fatigue is persistent.
Dry Skin:

Dry skin may occur as a side effect. Using moisturizers and avoiding harsh skincare products may help manage this symptom.
Mouth Sores:

Some individuals may develop mouth sores. Practicing good oral hygiene and reporting any persistent sores to the healthcare provider is recommended.
Nail Changes:

Changes in the nails, such as brittleness or discoloration, may occur. Patients should report significant changes to their healthcare provider.

Uses

Uses of Geftib 250 MG Tablets

The key uses of Geftib 250 MG Tablets include:

Treatment of Advanced or Metastatic NSCLC:

Geftib 250 MG Tablets are prescribed for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). This is a specific type of lung cancer that has spread beyond the lungs.
EGFR Mutation-Positive Tumors:

Geftib is particularly effective in cases where the tumors have specific mutations in the epidermal growth factor receptor (EGFR) gene. These mutations make the cancer cells more responsive to the inhibitory effects of Gefitinib, the active ingredient in Geftib 250 MG Tablets.
Targeted Therapy for EGFR-Mutated NSCLC:

The medication acts as a targeted therapy by inhibiting the activity of EGFR, a protein that plays a crucial role in the growth and division of cancer cells. Geftib is specifically designed to target NSCLC with EGFR mutations.
Improvement of Overall Survival:

Geftib is prescribed with the goal of improving overall survival and managing the progression of NSCLC in patients with EGFR mutations.
Individualized Treatment Plans:

Treatment plans involving Geftib are individualized, and the decision to use this medication is based on genetic testing results, the specific type of EGFR mutation present, and the overall health of the patient.


How to use Geftib 250 MG Tablets?

Prescription and Guidance:

Geftib 250 MG Tablets should be prescribed and provided by a qualified healthcare professional. Patients should follow the specific instructions and guidance given by their healthcare provider.
Dosage:

The dosage of Geftib 250 MG is determined by the healthcare provider based on the patient's medical condition, genetic profile, and overall health. Patients should take the prescribed dosage as directed.
Administration:

Geftib 250 MG Tablets are usually taken orally. The tablets can be taken with or without food, as directed by the healthcare professional. Patients should swallow the tablet whole with a glass of water and not crush or chew it.
Consistency in Timing:

Patients are advised to take Geftib at the same time each day to maintain a consistent level of the medication in the body.
Missed Dose:

If a dose is missed, patients should follow the guidance provided by their healthcare provider. It is generally advisable not to double up on doses to make up for a missed one. Patients are encouraged to contact their healthcare provider for specific instructions.
Duration of Treatment:

The duration of Geftib 250 MG treatment is determined by the healthcare provider based on the patient's response to the medication and the progression of the disease. Patients should continue taking the medication for as long as prescribed.
Regular Monitoring:

Regular medical check-ups and monitoring are essential during the course of treatment. This may include tests to assess the effectiveness of the medication and to manage potential side effects.
Precautions:

Patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or other medications they are taking to avoid potential interactions.
Communication with Healthcare Provider:

Patients are encouraged to communicate openly with their healthcare provider about any concerns, side effects, or changes in health during the course of Geftib 250 MG treatment.
Pregnancy and Breastfeeding:

Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss these considerations with their healthcare provider. Geftib may have potential risks during pregnancy.

Review

No Review Found!

Post Your Comments

Disclaimer

The information provided on website is intended for educational purposes only and should not be used as a substitute for professional medical advice. Please consult a qualified healthcare professional for personalized medical advice.

icon

Registered Pharmacy

with branches throughout the USA

icon

Completely secure service

Your information is in safe hands.

icon

Fast, Free & discreet Shipping

on all standard USA orders over $ 250